Since CD38 (cyclic ADP-ribose hydrolase 1) expression in CLL cells has been associated with unmutated IGHV and shorter overall survival in patients with CLL, CD38 was proposed as a surrogate marker of the IGHV somatic mutation status in CLL [20,22,23]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.